Addex Therapeutics Ltd. (ADXN) stock
ADXNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.06−0.44 (-12.57%)
Close on Nov 18, 2026Market cap $62.83KP/E –Yield –
Addex Therapeutics price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Addex Therapeutics's price to sales ratio was 1.7× on Nov 11, 2026, against 0.3× a year earlier. Over the last 5 years it ranged from 0.0× to 3.7×, with a median of 0.1×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.7× | +1.4 |
| 2025 | Dec 31, 2025 | 0.3× | +0.2 |
| 2024 | Dec 31, 2024 | 0.1× | +0.0 |
| 2023 | Dec 29, 2023 | 0.0× | +0.0 |
| 2022 | Dec 30, 2022 | 0.0× | −0.1 |
| 2021 | Dec 31, 2021 | 0.1× | −0.2 |
| 2020 | Dec 31, 2020 | 0.3× | – |
See a number that looks wrong?